AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2022
Nov 23, 2022
31542_dirs_2022-11-23_27db7822-6fde-42cb-bcf8-4ad5f0337569.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2022-11-21
Reporting Person: COELHO PHILIP H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-21 | Common stock, par value $0.001 per share | S | 70000 | $15.231 | Disposed | 179553 | Direct |
| 2022-11-22 | Common stock, par value $0.001 per share | S | 20001 | $17.304 | Disposed | 159552 | Direct |
| 2022-11-23 | Common stock, par value $0.001 per share | S | 9999 | $17.45 | Disposed | 149553 | Direct |
Footnotes
F1: Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Coelho remains a director of the Company.
F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.01 to $15.59 per share.
F3: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.28 to $17.335 per share.
More from CATALYST PHARMACEUTICALS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jul 8
Proxy Solicitation & Information Statement
2026
Jun 30
Regulatory Filings
2026
Jun 30
Regulatory Filings
2026
Jun 23
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Call Transcript
2026
Mar 10
Call Transcript
2026
Feb 26